Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Danimer Scientific Inc DNMR

Danimer Scientific, Inc. is a performance polymer company. The Company specializes in bioplastic replacements for traditional petroleum-based plastics. Its technologies include Polyhydroxyalkanoate (PHA)-based Resins, Polylactic acid (PLA)-based Resins and Rinnovo. It harvests the PHA from the bacteria, then purifies and filters the bioplastic before forming the non-formulated PHA into pellets. Its PHA is a naturally occurring bioplastic that effectively biodegrades in both anaerobic environments, such as a waste treatment facility, and aerobic environments. It sells the PHA under its proprietary Nodax brand name. PLA is made from dextrose derived from corn, sugar beets and sugar cane, among other sources. Applications for biopolymers include additives, aqueous coatings, fibers, filaments, films, thermoforming, and injection-molded articles. The Company primarily markets its products to consumer packaging brand owners, converters and manufacturers in the plastics industry.


NYSE:DNMR - Post by User

Post by CommonCentsforDollarson Apr 06, 2021 2:06pm
117 Views
Post# 32942701

US EPA

US EPAhttps://cfpub.epa.gov/ncer_abstracts/index.cfm/fuseaction/display.abstractDetail/abstract/11022/report/0

Renewable Bioplastics Production

EPA Contract Number: 68HERC20C0004
Title: Renewable Bioplastics Production
Investigators: Imam, Tahmina
Small Business: Altex Technologies Corporation
EPA Contact: Richards, April
Phase: II
Project Period: November 1, 2019 through October 31, 2021
Project Amount: $299,998
RFA: Small Business Innovation Research (SBIR) - Phase II (2019) Recipients Lists
Research Category: Small Business Innovation Research (SBIR)

Description:

Current petroleum-derived-plastics contain additives such as phthalates or bisphenolA that are harmful to human health and the environment. Thus, it’s critical to replace such toxic non-biodegradable plastics with biodegradable bioplastics. To meet bioplastics production need, Altex, and Texas A&M University (TAMU) have teamed up to utilize renewable biomass, such as forest residue, agricultural waste, corn stover etc., to produce polyhydroxyalkanoates, PHA for green-bioplastics-production, using a feed-flexible, chemicals free pretreatment, and environment friendly microbial conversion process called Renewable Bioplastics Production (RBP).

Most bioplastics being produced are from cellulose structure of the plant, resulting in low yield and high cost. During EPA-Phase I, the RBP process was successfully performed in bench scale to produce PHA from the Altex pretreated biomass. The RBP test results showed that it’s a high yield-low cost process, where a PHA yield of 53% was achieved from lingo-cellulosic biomass. Economic analysis showed a bioplastics production cost of $0.26/lb. With a selling price of $1.1/lb (to be competitive with plastic – $0.9 to $3/lb), a simple payback is half a year. Altex RBP plant also reduces GHG emissions by 0.84 to 152 MM tons/year depending on different biomass. This is significant effect on our environment.

Under the proposed Phase II Altex has added Danimer Scientific, a bioplastic manufacturer, to the Altex-TAMU team to demonstrate the end-to-end biomass to bioplastics production. During Phase II, Altex and the team members will optimize the PHA extraction from cells to maximize the bioplastics yield and develop extrusion method to produce bioplastics resins for a final sellable consumer product, such as water bottles. These activities will help Altex define the specific bioplastics product and follow the respective market for commercialization. Altex will work with its’ commercialization partner, Danimer Scientific to assess the RBP Bioplastics. Their products include biodegradable water bottles for Nestl. There is a substantial synergy between Altex’s PHA and Danimer approach.

Altex’s business model is to license the RBP technology to Danimer, adding a cheaper bioplastic to their current product line as a potential licensee of RBP technology. Low cost of RBP allows the product to be competitive with plastic and capture a vast market. According to European Bioplastics Association, bioplastics represent about 1% of the 320 million tonnes of plastic produced annually and is growing. The targeted final customers are the ones that currently use petroleum- sourced plastic products. The product’s low cost and its low carbon foot print will attract these customers.

 

<< Previous
Bullboard Posts
Next >>